drugset

drugset / Trial / NCT01213199

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

NCT01213199 ↗

Phase 2 Completed 20 enrolled Galderma R&D

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

Timeline

Start: 2011-03
Primary completion: 2012-04
Completion: 2012-09

Publications

Loss MJ, Leung S, Chien A, Kerrouche N, Fischer AH, Kang S. Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars. Dermatol Ther (Heidelb). 2018 Jun;8(2):245-257. doi: 10.1007/s13555-018-0231-8. Epub 2018 Mar 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adapalene	Other / unclassified	0.3 %	Topical

Indications